Anabolic Steroid Control Act PassedThe bill will now be sent to the President's office to be signed into law. CRN's commitment to protecting consumers from dangerous substances masquerading as dietary supplements is longstanding. CRN lobbied Congress to pass the Anabolic Steroid Control Act of and has tenaciously led the charge for the dietary supplement industry since that time, ramping up activities in with outreach to legislative offices on Capitol Hill in support of DASCA, underscoring its value to consumers as well as to responsible dietary supplement companies. DASCA will protect consumers as well as zteroid companies by empowering the Drug Enforcement Administration DEA with new tools to identify and rapidly steroiv anabolic steroid control act illegal drugs in the form of new anabolic steroid control act anabolic steroids are wnabolic marketed as dietary supplements. For instance, the law calls for DEA to address products that are "substantially similar" to anabolic steroids and that have been illegally marketed to promote muscle dianabol sexdrive DASCA will allow DEA to quickly crack down on criminals dontrol new anabolic substances that closely resemble red-flagged counterparts listed, but altered minimally with the intent nap 50 steroids review evading enforcement.
Anabolic Steroid Control Act of (; th Congress S. ) - omosironews.info
Specifically, the text of the bill reads: For purposes of this subparagraph, a violation is defined as each instance of importation, exportation, manufacturing, distribution, or possession with intent to manufacture or distribute.
The bill further reads: For purposes of this paragraph, the term at the retail level refers to products sold, or held for sale, directly to the consumer for personal use. Each package, container or other separate unit containing an anabolic steroid that is distributed, dispensed, or possessed with intent to distribute or dispense at the retail level in violation The President signed the bill into law on December 18, Anabolic steroids, technically known as anabolic-androgenic steroids AAS , are drugs that are structurally related to the cyclic steroid ring system and have similar effects to testosterone in the body.
They increase protein within cells, especially in skeletal muscles. Anabolic steroids were first made in the s, and are now used therapeutically in medicine to stimulate muscle growth and appetite, induce male puberty and treat chronic wasting conditions, such as cancer and AIDS. The American College of Sports Medicine acknowledges that AAS, in the presence of adequate diet, can contribute to increases in body weight, often as lean mass increases and that the gains in muscular strength achieved through high-intensity exercise and proper diet can be additionally increased by the use of AAS in some individuals.
Health risks can be produced by long-term use or excessive doses of anabolic steroids. Ergogenic uses for anabolic steroids in sports, racing, and bodybuilding as performance-enhancing drugs are controversial because of their adverse effects and the potential to gain unfair advantage is considered cheating. Their use is referred to as doping and banned by all major sporting bodies.
One estimate indicates that over 10 million Americans a year take anabolic steroids approximately four percent of whom are adolescents. The bill specified that a substance shall not be considered to be a drug or hormonal substance that is considered to be an anaboloic steroid if it is: Provides that any person claiming the benefit of an exemption or exception from being considered a drug or hormonal substance shall bear the burden of providing the appropriate evidence. This summary is based largely on the summary provided by the Congressional Budget Office , as ordered reported by the House Committee on Energy and Commerce on July 15, This is a public domain source.
Enacting the bill could affect direct spending and revenues; therefore, pay-as-you-go procedures apply. However, CBO estimates that any effects would be insignificant for each year. As a result, the government might be able to pursue cases involving drug use that it otherwise would not be able to prosecute.
CBO expects that H. Any such costs would be subject to the availability of appropriated funds. Because those prosecuted and convicted under H. Civil fines are recorded as revenues.
Criminal fines are recorded as revenues, deposited in the Crime Victims Fund , and later spent. CBO expects that any additional revenues and direct spending would not be significant because of the small number of additional cases likely to be affected. The bill would impose private-sector mandates by adding 25 new compounds, and any compounds found to be structurally similar, to the list of anabolic steroids regulated under the Controlled Substances Act. Consumers would need a prescription from a licensed practitioner in order to purchase products containing the newly listed compounds.
Sellers, manufacturers, and importers of such products would be required to obtain an authorization from state and federal authorities in order to make or possess the compounds. However, based on information from the Food and Drug Administration FDA , the DEA, and industry professionals, CBO expects that the majority of the affected entities would either replace the regulated compounds with new ones or discontinue the distribution of the affected products.
Therefore, the cost of the mandate would be the forgone income from lost sales. Because of the nature of the market being regulated, the scope of sales affected is difficult to determine.
As products are found to contain compounds that are structurally similar to the compounds listed, industry sales could decline significantly. Those figures include sales of some products that already are not in compliance or not being sold in compliance with FDA or DEA regulations. Although identifying which items would be affected by the legislation would be difficult, given the estimated magnitude of industry profits, even a 10 percent decrease in income as a result of the bill would exceed the annual threshold for private-sector mandates.
The bill also would impose a mandate on importers, exporters, manufacturers, and distributors by requiring that any anabolic steroid or product containing an anabolic steroid be labeled as such, using the nomenclature of the International Union of Pure and Applied Chemistry. The cost of the mandate would probably be small. Pitts, who sponsored the bill, said that the bill "will protect consumers from these harmful products by giving the DEA the tools and authority to classify designer steroids as controlled substances.
Delegate Donna Christensen D-VI was also in favor of the bill, arguing that it "will go a long way to removing dangerous steroids from the market.
Supporters argued that the bill would "make it easier for the attorney general to identify legally sold commercial products that contain illicit anabolic steroids. From Wikipedia, the free encyclopedia.
Introduced in the House as H. Wikisource has original text related to this article: